At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health industries.
Our fundraising tracker provides updated coverage of noteworthy digital health and health tech funding rounds, though we’ll still profile exciting new companies and larger rounds that catch our eye in depth.
Do you have fundraising news to share? Email Heather Landi at [email protected].
March
March 23—Doctronic
Integrating AI into healthcare organizations
Series: B
Amount: $40 million
Investors: Co-led by Abstract and Lightspeed Venture Partners.
Doctronic offers consumers free access to an AI doctor and operates its own clinical practice, licensed in all 50 states, HIPAA-compliant, and available 24/7. The startup is now seeing more than 300,000 unique weekly visitors.
The startup partners with major health systems, third-party administrators and self-insured employers across the counattempt. In December, it launched a prescription renewal service in Utah, which allows patients to receive medication refills directly via AI without physician approval. It works with 190 medications and includes clinician escalation for complex cases.
Where the Doctronic AI is practicing medicine indepfinishently, such as in Utah, the company states it has a unique AI medical malpractice insurance.
The company states it has direct access to patient records via QHIN/TEFCA, medication history through Surescripts and drug interaction screening through First Databank.
With the series B funding, Doctronic will expand partnerships with hospital systems, academic institutions, digital health platforms and payers. It will also fund expansion into pediatrics, where consumer demand far outpaces access. It’s in active discussions with regulators in other states and governments to expand AI prescription services beyond Utah.
“Doctronic proved what we believed from the start: AI can deliver better healthcare outcomes at scale,” stated Ramtin Naimi, Abstract partner, in a statement. “The Utah program validated their clinical rigor. The revenue growth validated market demand. What sets them apart is the courage to take responsibility for outcomes—not just provide information. That’s the future of healthcare.”
March 20—Latent Health
Advancing agentic AI for medication access
Series: A
Amount: $80 million
Investors: Co-led by Spark Capital and Transformation Capital, with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator
Latent Health aims to utilize artificial innotifyigence to speed up the prior authorization process for medications, particularly specialty medications. The company brings clinical innotifyigence directly into the patient record, supporting care teams shift patients from clinical decision to therapy rapider and more reliably. Latent is utilized by clinicians, physicians and pharmacists at more than 45 health systems, including Yale New Haven Health, Ochsner Health, MetroHealth, UCI, Vanderbilt Health, Mount Sinai Health System, Henry Ford Health System, UCSF Health and UCLA Health.
The company is building a clinical reasoning engine that performs clinical knowledge work by reasoning through patient data, interpreting drug criteria, extracting key evidence, and orchestrating workflows across stakeholders.
By connecting the EHR, payer guidelines, pharmacy operations and patient engagement with a single engine, Latent replaces the fragmented, manual work that sits between a doctor’s order and a patient’s treatment with AI agents that perform it instantly and at scale, all to support providers shift a patient from decision to therapy the same day, the company stated.
Latent started with prior authorization with high provider burnout, high stakes where patients can abandon therapy and complex clinical decision-creating. The company is now expanding its engine across every process where clinical knowledge must be translated into action.
With the Series A financing, the company will expand its health system footprint, deepen the platform connecting hospitals, payers, pharmacies, and patients, continue investing in the reliability and trust required to operate in healthcare, and scale the team. Latent is a home for exceptional talent who believe responsibility doesn’t finish at diagnosis, it extfinishs to creating sure patients actually receive care. Release
March 19—Lantern
Specialty care platform for surgery, infusions, and cancer care
Series: Undisclosed
Amount: $30 million
Investors: Morgan Health, a division of JPMorganChase, and Echo Health Ventures, a strategic investment platform investing on behalf of multiple Blues health plans, led the round.
Lantern, a specialty care platform currently serving 12 million people, saw strong growth in 2025, adding more than 100 new clients representing millions of new member lives. Lantern has also added Thermo Fisher Scientific, Amtrak, Hillsborough County Schools, Cleveland Bakers and Teamsters Health & Welfare Fund, and other national employers.
With the $30 million investment, Lantern plans to expand across public and private employers and health plans.
Lantern’s approach centers on its “Network of Excellence” model. Rather than relying solely on traditional centers of excellence – which concentrate care within a limited number of facilities – Lantern nereceivediates directly with high-quality providers to create the most accessible, high-performing network in the counattempt. Lantern’s model works across the three largest cost centers in specialty care: surgery, cancer, and infusions, where site of care shifts combined with high-quality specialists demonstrate savings up to $20 per employee per month (PEPM) across Lantern’s customers. Today, Lantern’s clients include more than 1,000 of the largest public and private employers and unions in the U.S.
Lantern’s platform is designed to lower total medical spfinish, improve surgical outcomes, reduce downstream costs and provide a better experience for members.
We are restoring basic market dynamics in specialty care to bfinish the healthcare cost curve,” stated John Zutter, CEO of Lantern. “We leverage robust cost analytics, clinical data on outcomes, appropriateness measures, and dynamic value-based contracting to receive people to great care, close to home.” Release
March 19—Health Universe
Integrating AI into healthcare organizations
Series: Seed
Amount: $6 million
Investors: Led by Kleiner Perkins, follows a pre-seed funding round with participation from Susa Ventures, Twelve Below and Oncology Ventures.
Health Universe, launched in 2023, is an enterprise artificial innotifyigence platform that automates healthcare workflows.
Its AI platform deploys inspectable, auditable agents to regulated healthcare settings, including for oncology and clinical trials. It is also building an agent-to-agent marketplace. The company’s navigator tool, which manages agents that run patient records, has processed more than 170 million clinical documents since its launch less than a year ago.
“Healthcare doesn’t required another chatbot,” stated Dan Caron, Health Universe founder and CEO, in the announcement. “It requireds AI systems that are traceable, compliant, and built for real clinical workflows. Our infrastructure allows organizations to deploy agents that solve high-priority utilize cases quickly, usually in a matter of days or weeks, not months or years. And we provide the security, inspectability, and auditability that academic medical centers and healthcare stakeholders require. This new funding allows us to scale these capabilities and bring trusted AI agents and models to more institutions and health systems across the counattempt.”
March 17—Conduit Health
Simplifying DME procurement
Series: A
Amount: $17 million
Investors: Led by Drive Capital, with participation from XYZ Ventures, Twelve Below, Eniac Ventures & others
Conduit Health, launched in 2024, combines clinical evaluation, insurance authorization and medical supply fulfillment in a single coordinated system. For the equipment a patient requireds, Conduit connects them to a licensed provider and manages prescribing, coverage verification and delivery. It specifically focutilizes on Medicare and Medicaid patients.
Its agentic AI platform is trained on over 50,000 patient interactions to predict approval likelihood before claims are filed and automate payer workflows to prevent bottlenecks. The startup works with over 100 payers and takes on denial risk.
It also works with referral partners that include managed long-term services and supports plans and provider organizations.
“The healthcare system creates it nearly impossible for individuals to obtain the home care equipment they required, covered by their insurance. [Cofounders Natan Wise and Rocky Sefte] identified this acute pain point, and the solution the team built feels like magic for the consumer,” Molly Bonakdarpour, general partner at Drive Capital, stated in an announcement. “Conduit is easily engaging the hardest to reach patients in healthcare by simply creating their lives simpler, and it displays in how rapid the company is growing.
March 12—Carefam
Automating healthcare HR
Series: Launch from stealth
Amount: $14.5 million
Investors: Pitango HealthTech, Emerge
Carefam, a conversational AI platform for healthcare HR, has launched from stealth. The startup’s AI gents are already deployed in hundreds of healthcare orgs across acute care, long-term care and home care settings. Its platform manages the entire HR process on behalf of recruiting teams, utilizing innotifyigent decision-creating to escalate sensitive or complex tinquires to humans as requireded.
As the healthcare indusattempt faces a workforce crisis, HR teams are overwhelmed by high turnover, manual processes and the complexity of staffing 24/7 operations, Carefam executives stated.
“The shortage of healthcare workers today is an infrastructure problem and will continue to worsen if things remain the same,” Matan Hoffmann, co-founder and CEO of Carefam, stated in an announcement.
March 11—Translucent
Using AI for insight into financial risk and ways to respond
Series: A
Amount: $27 million
Investors: Led by Google Ventures, with participation from NEA, Virtue, and FPV Ventures.
Translucent, launched in 2024, is the first agentic AI platform utilized for healthcare finance.
The company utilizes its platform to consolidate operational, clinical and financial data and continuously monitors for real-time financial insights. The platform is utilized at healthcare systems across the counattempt, including at Duly Health and Care and Springfield Clinic.
Translucent plans to utilize funding to accelerate product development and expand its footprint at health systems across the nation.
“Healthcare organizations are in trouble, and the financial infrastructure that should support leaders respond is fundamentally broken. That’s why healthcare requireds a true financial operating system built for this moment,” stated Jack O’Hara, Translucent founder and CEO, in a statement. “We built Translucent to give hospitals and clinics what they desperately required: real-time clarity and control, so they can catch problems early enough to act and keep their doors open for the patients who required them.”
March 10—Amigo AI
Training AI clinical agents
Series: A
Amount: $11 million
Investors: Led by Madrona, with participation from Optum Ventures.
Amigo AI is a platform that builds and trains AI agents to directly interact with patients across the spectrum of care, including intake and personalized care navigation.
The platform’s agents have completed over three million patient encounters globally with zero safety incidents in the past six months. Amigo has partnered with healthcare organizations around the world, including Eucalyptus and The Care Clinic.
The company partners with healthcare organizations to define AI strategies and build custom agents offered in more than 100 languages.
“Amigo is addressing one of the hardest problems in healthcare AI, deploying autonomous systems where trust and safety are non-nereceivediable,” stated Sabrina Albert, Partner at Madrona, in a statement. “Their simulation-first approach to clinical safety positions them to define the standard for patient-facing AI.”
March 10—Nitra
AI operating system for healthcare practices
Series: A and B
Amount: $187 million
Investors: Actions Capital, AppWorks, Comma Capital, Dunamu & Partners, Era Funds, New Enterprise Associates (NEA), Pantera Capital, and Sazze Partners. Funding also included participation from AAF, Gaingels, Hyphen Capital, K8, Mana Ventures, Necessary Ventures, PIDC/Uni-President, Purestone Silks, SignalRank, Simu Liu’s Markham Valley Ventures, Soma Capital, and others.
Nitra, launched in 2024, embeds AI agents directly into healthcare practices’ operational backbones.
The platform is an all-in-one offering that provides healthcare practices with financial automation, patient management and content and inventory. It is utilized by more than 700 clinics, and is on track to be implemented in 3,000 in 2026.
The company plans to plans to launch additional offerings to the platform in revenue cycle management, patient marketing, payroll and staffing.
“We’re on a mission to serve the people that serve our communities and support doctors save time and money,” stated Tim Hwang, CEO of Nitra, in a statement. “Practices are running critical workflows across disconnected systems that were never designed to work toreceiveher. Nitra brings those layers toreceiveher into a single AI-native operating system that supports healthcare practices run their operations more efficiently.”
March 5—Sage
AI-powered insights to support senior care
Series: C
Amount: $65 million
Investors: Growth Equity at Goldman Sachs Alternatives, with participation from IVP and Goldcrest.
Sage creates an AI-powered platform for senior living and skilled nursing facilities with the goal of surfacing key insights sooner and relocating the indusattempt to a more proactive model of care. Sage has raised $124 million to date.
An estimated 72 million Americans will be of retirement age by 2030. But healthcare faces a shortage of providers and licensed caregivers. Labor alone will not resolve this looming crisis, Sage argues. Real-time data insights are crucial to empowering caregivers and supporting them intervene in care early. Sage-powered communities have identified a $275 increase in net operating income per resident per month, 50% reduction in falls and 50% rapider response times compared to the indusattempt, the company claims.
The latest capital will be utilized to build out a predictive engine that analyzes daily activity patterns and other fall-risk signals to identify high-risk residents before an adverse event happens. Sage is also working to centralize data from EHRs into a single real-time care view to surface important context at the point of care. Additionally, Sage will deepen its capabilities for skilled nursing facilities, which operate under demanding clinical and regulatory conditions.
“We are experiencing a structural shift in the senior care market, necessitating a complete modernization of its underlying technology,” Antoine Munfa, managing director at Growth Equity, stated in an announcement.
“By shifting the indusattempt from a reactive to a proactive model, Sage is creating the scalable infrastructure to support meet the historic demand of an aging population,” stated Ryan Leary, Vice President within Growth Equity at Goldman Sachs Alternatives. Release
March 4—UnityAI
Building an autonomous workforce for healthcare operations
Series: A
Amount: $8.5 million
Investors: Third Prime, with participation from Nashville Capital Network, Whistler Capital Partners, Max Ventures, Company Ventures and other existing investors
Companies are quickly deploying AI agents to tackle isolated tinquires in healthcare. Taking a different approach, startup UnityAI is building what it calls autonomous operations, with agentic AI that has broader context and capabilities to optimize and continuously manage day-to-day clinic operations from the patient, provider and administrative sides.
UnityAI works with outpatient and specialty care practices to deploy an autonomous AI workforce designed to run core healthcare operations like patient scheduling, follow-ups, referrals and staffing coordination. Its AI agents unify and coordinate fragmented workflows and processes into a single, continuously operating system. These agents work across patient operations – scheduling and rescheduling, confirmations, follow-ups, and referrals and staffing operations – capacity optimization, shift management, PTO and coverage.
“Crossing the ‘last mile’ – actually engaging a person through voice AI to complete a tinquire – has shifted us from simply optimizing workflows to operating them autonomously,” UnityAI co-founder and CEO Edmund Jackson stated in a press release.
The company already is operating at nationwide scale, working with large specialty care groups like Tennessee Oncology and Peregrine Health, as well as national dental service organizations, value-based care providers and community and academic health systems. The company supports more than 300,000 patient interactions per month across hundreds of sites of care.
UnityAI touts strong results and ROI from provider deployment of its AI platform. At one national outpatient provider with more than 300 sites, UnityAI’s agentic workforce supported drive a 26% improvement in scheduler productivity and a 30% reduction in no-display rates.
Other measured impacts delivered by UnityAI across all of its customers include 90% of scheduling tinquires completed without staff involvement, less than 6% escalation to human teams, 2x higher patient reach rates compared with traditional workflows, 25% increase in converted referrals and 65% workforce savings in supported operational areas.
UnityAI is integrated with major EHR platforms and is continuing to expand its roadmap into additional areas of operational decision-creating. This includes staffing coordination capabilities that are now in beta across approximately 75 sites, in addition to advanced scheduling optimization designed to further improve access and efficiency.
The company will utilize the funding to scale go-to-market execution and extfinish its AI-powered operational capabilities. – Release
March 2—Ease Health
Re-architecting the behavioral health technology stack
Series: A
Amount: $41 million
Investors: Andreessen Horowitz
Behavioral health providers operate on fragmented, legacy software technology stacks that were not designed for the complexity of today’s modern care delivery. Admissions teams juggle disconnected CRMs and intake tools, clinicians document in EHRs built off paper workflows, and billing teams rely on manual, error-prone workflows.
Ease was built from the ground up to replace this patchwork with one AI-native system purpose-built for behavioral health.
The company’s tech unifies customer relationship management, electronic health record and revenue cycle management into a single platform designed to materially improve access to care, clinician experience, and provider economics across the behavioral health ecosystem.
Ease designed its platform to span the full patient lifecycle, from referral and intake through clinical care, billing and collections. By consolidating what are traditionally six to 10 separate systems into one, Ease reduces administrative overhead, eliminates redundant workflows, and enables automation across the most cost-intensive areas of behavioral health operations, according to the company.
Ease already supports a wide range of behavioral health levels of care, including outpatient, intensive outpatient (IOP), partial hospitalization (PHP), residential treatment, detox, and inpatient psychiaattempt, as well as medication-assisted treatment (MAT) across applicable settings. Ease works with both indepfinishent providers and large, multi-location provider groups, serving organizations across the United States.
The company’s approach has already demonstrated meaningful impact for customers, including reductions in third-party software spfinish through consolidation, rapider time-to-admission, improved clinical documentation efficiency and materially improved billing throughput and collections performance, executives stated.
The new funding will be utilized to expand Ease’s product and engineering teams, accelerate development of AI-powered automation across the platform and support continued growth with enterprise behavioral health providers.- Release
February
Feb. 26—Salma Health
Integrated brain health centers of excellence
Series: A
Amount: $80 million
Investors: Mubadala Capital and ARCH Venture Partners with participation from Linreceivedto Horizon, as well as others, including Averin Capital
Salma Health launched as a next-generation brain health company that integrates advanced diagnostics, rapid-acting interventions and continuous care coordination under one roof. With the fresh financing, Salma Health is positioned to build and operate centers of excellence designed to fundamentally reshape how brain conditions are diagnosed, treated and studied, the startup stated.
Salma Health’s integrated model connects front-line clinical care with scientific research to deliver breakthrough therapies for individuals living with psychiatric and psychological conditions, memory and dementia disorders, headache and migraines and brain injuries.
More than one-third of Americans experience a brain health condition each year. Yet care remains fragmented, siloed and slow, especially for patients whose requireds span psychiaattempt, neurology, psychology and crisis care. Salma Health directly addresses this gap through an integrated, technology-enabled model. The company operates specially equipped clinics for in-person healthcare services augmented by telehealth solutions. These clinics deliver advanced therapeutics, intensive care programs, crisis mitigation and patient support across a full spectrum of psychiatric and neurological services for all levels of acuity.
Salma Health’s model includes clinical research capabilities conducting clinical trials to support pharmaceutical and medical device companies and an AI-driven technology platform. Its Brain Health OS is an innotifyigent operating system that unlocks clinical insights, enhances decision support and streamlines care coordination. – Release
Feb. 26—Third Way Health
Hybrid AI-human operational efficiency
Series: A
Amount: $15 million
Investors: Health Velocity Capital
Third Way Health developed hybrid human and AI operating solution for healthcare practices, currently supporting practices that collectively serve more than 5 million patients each year.
Today’s healthcare practices are overwhelmed by unprecedented administrative complexity, driven by outdated technology and fragmented processes. The result is widespread staff burnout and subsequent turnover, delayed patient care, and mounting financial pressure for providers and health systems.
The company provides comprehensive front office services, from scheduling to prior authorization, through a white-glove implementation model that transforms operations in as little as 12 weeks. Fully dedicated teams are embedded in clients’ workflows, creating seamless, scalable operational support. To date, Third Way Health has supported clients reduce front-office administrative costs by up to 40%, increase patient visits by 11% on average, and cut phone wait times in half.
Third Way Health will utilize the funding to accelerate customer growth, expand its operational footprint and further advance its automation roadmap. The company plans to invest in scaling its sales and implementation teams, deepening its AI capabilities and enhancing its platform to support a growing base of customers.
“We are at an inflection point where innotifyigent automation can truly optimize practices, freeing healthcare providers to focus on patients,” stated Frederik Mueller, co-founder and CEO of Third Way Health. “Healthcare practices are ready for solutions that offer sustainable growth, and we are excited to lead the charge. We operate as a true extension of our customers’ teams, relocating at their pace, absorbing operational volatility, and advocating relentlessly for what’s best for the practice so that every partnership delivers a genuine win-win. With this funding, we can continue redefining front-office operations and patient care.” – Release
Feb. 25—Baba
Medicare-covered patient advocacy platform
Series: Seed
Amount: $6.5 million
Investors: General Catalyst, with participation from Genius Ventures, Soma Capital, Ground Up Ventures, Triedge Investments and others
Startup Baba emerged from stealth funded with $6.5 million in seed funding to address a growing gap support older adults navigate care.
The company developed a Medicare- and Medicare Advantage-covered patient advocacy platform that assigns dedicated human advocates to work longitudinally with patients and caregivers, positioning patient advocacy as reimbursable healthcare infrastructure rather than a private-pay add-on.
While healthcare coverage may exist, many older adults still struggle to navigate insurance appeals, coordinate across providers, and manage follow-through after discharge.
To date, Baba has supported more than 6,000 families navigating complex care requireds. The company partners with nursing homes, home care agencies and home health organizations nationwide to connect patients with Baba’s dedicated advocates during care transitions. Baba is enrolling in an IRB-approved clinical study with Johns Hopkins to indepfinishently evaluate the impact of its advocacy model on health and claims outcomes.
The new capital will support expansion across Medicare and Medicare Advantage populations and deepen partnerships in provider and post-acute settings.
Baba’s advocates, who are usually nurses or social workers, manage the operational breakdowns that most often derail care plans, including insurance challenges, scheduling issues and care coordination, while working alongside providers rather than outside the system.
Baba also offers a phone- and text-based AI companion that provides daily engagement, reminders, and early signals when barriers to care arise, allowing advocates to intervene quickly and manage follow-through. Release
Feb. 19—Frist Cressey Ventures
Fund focutilized on early-stage, tech-driven companies
Series: Fund IV
Amount: $425 million
Investors: N/A
FCV’s oversized fund close brings the venture capital firm’s total assets under management to nearly $1 billion. The new fund will drive the firm’s focus on early-stage companies focutilized on transforming care delivery with tech and tech-enabled services, including AI-native business models.
“As we enter this next chapter, we’re excited to build strong, transformative, and finishuring partnerships – and to serve as a trusted partner to the leaders and companies shaping the future of patient-centered care,” Former Sen. Bill Frist, M.D., co-founder and managing partner at FCV, stated in the announcement.
The firm celebrates its 10-year anniversary this year. It has built 44 investments and has seen 14 successful exits. FCV has partnered with The Cigna Group Ventures, MedStar Health and OhioHealth. Its strategic LPs collectively provide healthcare to over half the U.S. population.
Feb. 17—Daffodil Health
AI for health plan admin, claims processing
Series: A
Amount: $16.3 million
Investors: Led by Flare Capital Partners, with participation from LRVHealth and Maverick Ventures, plus individual investors.
The capital will be utilized for product development and to expand work with payers and third-party administrators. Daffodil aims to support with price transparency, automated nereceivediations and real-time claims support. The startup argues legacy claims systems can’t support the flexible plan designs growing popular.
“For too long, health plans have been unable to meaningfully address the healthcare cost crisis becautilize they’ve been forced to pay high fees to middlemen whose incentives often create the problem worse,” Navin Nagiah, CEO and co-founder of Daffodil Health, stated in an announcement. “By giving plans control over pricing logic and real visibility into claims, we’re striving for more transparent, auditable, and cost-effective benefit design across the board.”
Daffodil utilizes AI and large language models to support clients bring out-of-network repricing and payment integrity in-houtilize, with minimal or no increases in labor costs. Across current partnerships, Daffodil claims to deliver seven-figure improvements in plan margins. One payer partner has saved about $4 million in the first year of the partnership solely through vfinishor fee reductions.
Feb. 13—Big Health
Digital therapeutics for mental health
Series: Undisclosed
Amount: $23.7 million
Investors: .406 Ventures and AlleyCorp led the round, with participation from CVS Health Ventures, Blue Venture Fund, Sandbox Clinical Ventures, Gilde Healthcare and Supermoon Capital.
Digital therapeutics developer Big Health plans to utilize the funding to accelerate access to its FDA-cleared, reimbursable solutions (SleepioRx for insomnia disorder and DaylightRx for generalized anxiety disorder). SleepioRx and DaylightRx are among just nine FDA-cleared treatments in the Centers for Medicare & Medicaid Services’ (CMS’) recently established category of digital mental health treatments (DMHTs), a new class of reimbursable medical device treatments for mental health conditions. Big Health’s latest funding follows the CMS DMHT policy, which created new G-codes in the 2025 Physician Fee Schedule, enabling the first national Medicare coverage for FDA-cleared DMHTs such as SleepioRx and DaylightRx. Release
Feb. 12—Talkiaattempt
Telepsychiaattempt provider
Series: D
Amount: $210 million
Investors: Perceptive Advisors led the round, which the company stated was oversubscribed. Brussels-based investor Sofina also participated along with prior lead investors Andreessen Horowitz (a16z), blisce/ and Left Lane Capital, alongside a debt facility from Banc of California.
The company claims to be the largest private employer of psychiatrists and directly employs more than 800 full-time psychiatrists. Talkiaattempt is now in network with more than 100 insurers nationwide covering more than 170 million lives. The company has delivered 3 million patient visits to date. Talkiaattempt plans to utilize the fresh funding to build out its technology and expand its services across the acuity spectrum. Article
Feb. 12—Anterior
AI platform for health plans
Series: Undisclosed
Amount: $40 million
Investors: NEA and Sequoia Capital alongside new investors FPV and Kinnevik
Anterior works with health insurers to deploy artificial innotifyigence technology within the clinical workflow and pairs that tech with a clinician-led team that supports payers in optimizing accuracy and driving measurable impacts. Anterior founder and CEO Abdel Mahmoud, M.D., stated the platform is designed to ease the back-office burden for health plans, including prior authorization, payment integrity and risk adjustment. Article
Feb. 10—Solace Health
Patient advocacy platform
Series: C
Amount: $130 million
Investors: IVP led the round with participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital and RiverPark Ventures.
Solace Health connects Medicare and Medicare Advantage patients to trained healthcare advocates to improve their experience navigating the healthcare system and assist them in receiveting the care they required. Patients are matched with advocates on Solace Health’s digital platform. With the additional funds, Solace Health hopes to expand its national advocate network beyond its 2,000 existing advocates. Article
Feb. 10—Garner Health
Digital care navigation company for employers
Series: D
Amount: $118 million
Investors: Kleiner Perkins led the round, with Redpoint, Maverick, Kaiser Permanente Ventures, Mercy, Plus Capital and other existing investors also participating.
Founded in 2019, Garner utilizes data analytics and artificial innotifyigence to support employers and employees identify high-quality, cost-effective healthcare providers and then creates financial incentives for patients to see those doctors. It plans to utilize the fresh capital to expand its doctor ranking platform, scale its AI-driven navigation and appointment booking capabilities and grow its team. Article
Feb. 4—Chamber Cardio
Value-based care for cardiology practices
Series: A
Amount: $60 million
Investors: Frist Cressey Ventures led the series A round. Existing investors General Catalyst, AlleyCorp, American Family Ventures and Company Ventures also backed the round along with strategic participation from Optum Ventures, Healthworx Ventures and additional investment from Black Opal Ventures. The financing also includes debt from HSBC Innovation Banking.
The startup, which launched in 2022, provides cardiologists with a tech solution along with infrastructure for administrative and care team support and supports practices navigate value-based contracting. It plans to utilize the funding to build out its tech-enabled delivery platform that supports cardiologists in value-based care models. Article
Feb. 3—Midi Health
Virtual women’s health clinic
Series: D
Amount: $100 million
Investors: Goodwater Capital led the round, new investors Foresite Capital and Serena Ventures and existing investors Advance Venture Partners, GV (Google Ventures), Emerson Collective, SemperVirens and McKesson Ventures also backed the round.
The five-year-old startup, a Fierce 15 of 2025 honoree, is building a comprehensive healthcare platform that serves women across every life stage with an ongoing focus on midlife women’s health conditions. The company plans to offer new care lines addressing metabolic health, weight management, musculoskeletal health and long-term wellness. Article
Feb. 3—Lotus Health AI
AI doctor for primary care
Series: A
Amount: $35 million
Investors: Kleiner Perkins and CRV co-led the round, with backing from Joe Montana’s Liquid 2, Adidas Family Office’s LEADVC and a group of high-profile healthcare and technology founders and operators, including Jerry Murdock, Michael Ovitz, Aneesh Chopra, Vivek Garipalli, Othman Laraki, Travis May, Julia Cheek, Adrian Aoun, Harpreet Rai, Colin Evans, Jacob Reider, Harjinder Sandhu and Ian Shakil, alongside physicians from Harvard and Stanford.
Kleiner Perkins also led Lotus’ seed round, bringing total funding to $41 million. Lotus Health AI built an “AI doctor” that provides free primary care 24/7 in more than 50 languages. Lotus Health AI combines medical AI, unified patient health data, the latest peer-reviewed medical evidence, clinical guidelines and board-certified physicians reviewing guidance. The system automatically syncs medical records, labs, medications, wearable data and insurance benefits into one secure profile. Physicians review care, refine recommfinishations and prescribe medications when requireded. The company plans to add lab ordering and in-person care routing. Lotus Health AI will utilize the capital to build out the infrastructure, clinical team and the runway for its AI-powered primary care model. Release
Feb. 3—Alaffia Health
Agentic AI for health plan claims operations
Series: B
Amount: $55 million
Investors: Transformation Capital, with participation from insiders including FirstMark Capital, Tau Ventures and Twine Ventures
Founded in 2020 by sibling duo TJ Ademiluyi and Adun Akanni, Alaffia was built to address these challenges, drawing on firsthand experience growing a family business focutilized on revenue cycle management. Alaffia partners with leading regional and national health plans to support them scale clinical review capacity and unlock significant savings. Alaffia has delivered millions of dollars in medical cost savings, reduced turnaround times from weeks to days and improved consistency across findings. The startup will utilize the new capital to invest in R&D, launch new artificial innotifyigence agents across additional modalities to expand platform capabilities and scale AI adoption to meet rising demand across the healthcare ecosystem. Release
Leave a Reply